Congenital nemaline myopathy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:457074
Who is this for?
Show terms as
2Active trials6Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Congenital nemaline myopathy is a rare inherited muscle disorder that is present from birth. It belongs to a group of conditions called nemaline myopathies, which are named after tiny rod-shaped structures (called nemaline bodies or nemaline rods) that can be seen in muscle cells under a microscope. In the congenital form, babies are born with noticeable muscle weakness, often described as being "floppy" (hypotonia). This weakness primarily affects the muscles used for breathing, swallowing, and moving the arms and legs. Facial muscles are frequently involved, giving the face a long, less expressive appearance. The severity of congenital nemaline myopathy can vary widely. Some babies have very severe weakness that makes breathing and feeding extremely difficult from the start, while others have milder weakness that still allows them to reach some motor milestones, though often with delays. Common problems include difficulty feeding, a weak cry, respiratory insufficiency, and delayed motor development such as sitting and walking. There is currently no cure for congenital nemaline myopathy. Treatment focuses on managing symptoms and supporting quality of life. This may include respiratory support (such as ventilators or breathing machines), feeding tubes for nutrition, physical therapy to maintain muscle function and prevent joint stiffness, and orthopedic interventions for skeletal problems like scoliosis. Research into potential therapies is ongoing, and early intervention with a multidisciplinary care team can significantly improve outcomes.

Key symptoms:

Muscle weakness present from birthFloppy or low muscle tone (hypotonia)Difficulty breathing or respiratory insufficiencyDifficulty feeding or swallowingWeak cryLong or narrow faceDelayed motor milestones like sitting and walkingJoint stiffness or contracturesScoliosis or curved spineHigh-arched palateThin or slender body buildFoot deformities such as club footChest wall abnormalitiesNasal or weak-sounding speechFatigue and reduced endurance

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

FDA & Trial Timeline

4 events
Aug 2026Natural History Study for Patients With Nemaline Myopathy in Belgium

Centre Hospitalier Universitaire de Liege — NA

TrialNOT YET RECRUITING
Jun 2026Natural History Study for Patients With Nemaline Myopathy in Spain

Hospital Universitari Vall d'Hebron Research Institute

TrialRECRUITING
Jan 2025Nemaline Myopathy Clinical Research Network (NM-CTRN)

Stanford University

TrialNOT YET RECRUITING
Oct 2024Natural History Study for Patients With Nemaline Myopathy in the UK

University of Oxford

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Congenital nemaline myopathy.

2 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

2 recruitingView all trials with filters →
Other2 trials
Natural History Study for Patients With Nemaline Myopathy in the UK
Actively Recruiting
PI: Prof Laurent Servais (MDUK Oxford Neuromuscular Centre, University of Ox) · Sites: London; London +2 more
Natural History Study for Patients With Nemaline Myopathy in Spain
Actively Recruiting
· Sites: Barcelona

Specialists

6 foundView all specialists →
BP
Baziel van Engelen, Prof. PhD
Specialist
PI on 1 active trial
LM
Laurent Servais, MD
Specialist
PI on 6 active trials1 Congenital nemaline myopathy publication
KM
Kevin Strauss, MD
GORDONVILLE, PA
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Congenital nemaline myopathy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Congenital nemaline myopathyForum →

No community posts yet. Be the first to share your experience with Congenital nemaline myopathy.

Start the conversation →

Latest news about Congenital nemaline myopathy

Disease timeline:

New recruiting trial: Natural History Study for Patients With Nemaline Myopathy in the UK

A new clinical trial is recruiting patients for Congenital nemaline myopathy

New recruiting trial: Natural History Study for Patients With Nemaline Myopathy in Spain

A new clinical trial is recruiting patients for Congenital nemaline myopathy

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific gene mutation is causing my child's nemaline myopathy, and how does that affect the expected course of the disease?,What level of respiratory support does my child need now, and how will breathing function be monitored over time?,What feeding and nutritional strategies do you recommend, and when should we consider a feeding tube?,What physical therapy and rehabilitation programs are most beneficial for maintaining muscle function?,Are there any clinical trials or emerging treatments that my child might be eligible for?,What emergency signs should I watch for at home, and what is the plan if my child's breathing suddenly worsens?,How will this condition affect my child's growth, development, and long-term quality of life?

Common questions about Congenital nemaline myopathy

What is Congenital nemaline myopathy?

Congenital nemaline myopathy is a rare inherited muscle disorder that is present from birth. It belongs to a group of conditions called nemaline myopathies, which are named after tiny rod-shaped structures (called nemaline bodies or nemaline rods) that can be seen in muscle cells under a microscope. In the congenital form, babies are born with noticeable muscle weakness, often described as being "floppy" (hypotonia). This weakness primarily affects the muscles used for breathing, swallowing, and moving the arms and legs. Facial muscles are frequently involved, giving the face a long, less expr

At what age does Congenital nemaline myopathy typically begin?

Typical onset of Congenital nemaline myopathy is neonatal. Age of onset can vary across affected individuals.

Are there clinical trials for Congenital nemaline myopathy?

Yes — 2 recruiting clinical trials are currently listed for Congenital nemaline myopathy on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Congenital nemaline myopathy?

6 specialists and care centers treating Congenital nemaline myopathy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.